Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 22:00:15 UTC
Update Date2021-09-26 23:16:58 UTC
HMDB IDHMDB0259433
Secondary Accession NumbersNone
Metabolite Identification
Common NameZolmitriptan N-Oxide
Description2-{5-[(2-hydroxy-4,5-dihydro-1,3-oxazol-4-yl)methyl]-1H-indol-3-yl}-N,N-dimethylethanamine oxide belongs to the class of organic compounds known as 3-alkylindoles. 3-alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 3-position. Based on a literature review very few articles have been published on 2-{5-[(2-hydroxy-4,5-dihydro-1,3-oxazol-4-yl)methyl]-1H-indol-3-yl}-N,N-dimethylethanamine oxide. This compound has been identified in human blood as reported by (PMID: 31557052 ). Zolmitriptan n-oxide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Zolmitriptan N-Oxide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
SynonymsNot Available
Chemical FormulaC16H21N3O3
Average Molecular Weight303.362
Monoisotopic Molecular Weight303.158291548
IUPAC NameN,N-dimethyl-2-{5-[(2-oxo-1,3-oxazolidin-4-yl)methyl]-1H-indol-3-yl}ethanamine oxide
Traditional NameN,N-dimethyl-2-{5-[(2-oxo-1,3-oxazolidin-4-yl)methyl]-1H-indol-3-yl}ethanamine oxide
CAS Registry NumberNot Available
SMILES
C[N+](C)([O-])CCC1=CNC2=C1C=C(CC1COC(=O)N1)C=C2
InChI Identifier
InChI=1S/C16H21N3O3/c1-19(2,21)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-22-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)
InChI KeyGZYCQRZFJIZOKU-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as 3-alkylindoles. 3-Alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 3-position.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassIndoles and derivatives
Sub ClassIndoles
Direct Parent3-alkylindoles
Alternative Parents
Substituents
  • 3-alkylindole
  • Oxazolidinone
  • Substituted pyrrole
  • Benzenoid
  • Oxazolidine
  • Pyrrole
  • Carbamic acid ester
  • Trialkyl amine oxide
  • Heteroaromatic compound
  • Trisubstituted n-oxide
  • N-oxide
  • Azacycle
  • Oxacycle
  • Organonitrogen compound
  • Organic zwitterion
  • Organic oxide
  • Carbonyl group
  • Organic oxygen compound
  • Organic nitrogen compound
  • Organic salt
  • Organooxygen compound
  • Hydrocarbon derivative
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP-0.16ALOGPS
logP0.92ChemAxon
logS-4.1ALOGPS
pKa (Strongest Acidic)12.68ChemAxon
pKa (Strongest Basic)4.42ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area77.18 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity84.48 m³·mol⁻¹ChemAxon
Polarizability32.45 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+155.02630932474
DeepCCS[M-H]-152.66430932474
DeepCCS[M-2H]-186.3330932474
DeepCCS[M+Na]+161.52430932474
AllCCS[M+H]+172.932859911
AllCCS[M+H-H2O]+169.632859911
AllCCS[M+NH4]+176.032859911
AllCCS[M+Na]+176.832859911
AllCCS[M-H]-180.432859911
AllCCS[M+Na-2H]-180.732859911
AllCCS[M+HCOO]-181.332859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
Zolmitriptan N-OxideC[N+](C)([O-])CCC1=CNC2=C1C=C(CC1COC(=O)N1)C=C23967.4Standard polar33892256
Zolmitriptan N-OxideC[N+](C)([O-])CCC1=CNC2=C1C=C(CC1COC(=O)N1)C=C22365.0Standard non polar33892256
Zolmitriptan N-OxideC[N+](C)([O-])CCC1=CNC2=C1C=C(CC1COC(=O)N1)C=C23082.8Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Zolmitriptan N-Oxide,1TMS,isomer #1C[N+](C)([O-])CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3)C=C122829.2Semi standard non polar33892256
Zolmitriptan N-Oxide,1TMS,isomer #1C[N+](C)([O-])CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3)C=C122779.9Standard non polar33892256
Zolmitriptan N-Oxide,1TMS,isomer #1C[N+](C)([O-])CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3)C=C123972.6Standard polar33892256
Zolmitriptan N-Oxide,1TMS,isomer #2C[N+](C)([O-])CCC1=C[NH]C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C122797.5Semi standard non polar33892256
Zolmitriptan N-Oxide,1TMS,isomer #2C[N+](C)([O-])CCC1=C[NH]C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C122750.8Standard non polar33892256
Zolmitriptan N-Oxide,1TMS,isomer #2C[N+](C)([O-])CCC1=C[NH]C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C123571.6Standard polar33892256
Zolmitriptan N-Oxide,2TMS,isomer #1C[N+](C)([O-])CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C122764.4Semi standard non polar33892256
Zolmitriptan N-Oxide,2TMS,isomer #1C[N+](C)([O-])CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C122772.3Standard non polar33892256
Zolmitriptan N-Oxide,2TMS,isomer #1C[N+](C)([O-])CCC1=CN([Si](C)(C)C)C2=CC=C(CC3COC(=O)N3[Si](C)(C)C)C=C123280.8Standard polar33892256
Zolmitriptan N-Oxide,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C=C(CC[N+](C)(C)[O-])C2=CC(CC3COC(=O)N3)=CC=C213039.7Semi standard non polar33892256
Zolmitriptan N-Oxide,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C=C(CC[N+](C)(C)[O-])C2=CC(CC3COC(=O)N3)=CC=C213000.7Standard non polar33892256
Zolmitriptan N-Oxide,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C=C(CC[N+](C)(C)[O-])C2=CC(CC3COC(=O)N3)=CC=C213936.4Standard polar33892256
Zolmitriptan N-Oxide,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N1C(=O)OCC1CC1=CC=C2[NH]C=C(CC[N+](C)(C)[O-])C2=C13046.7Semi standard non polar33892256
Zolmitriptan N-Oxide,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N1C(=O)OCC1CC1=CC=C2[NH]C=C(CC[N+](C)(C)[O-])C2=C12988.0Standard non polar33892256
Zolmitriptan N-Oxide,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N1C(=O)OCC1CC1=CC=C2[NH]C=C(CC[N+](C)(C)[O-])C2=C13565.7Standard polar33892256
Zolmitriptan N-Oxide,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C(=O)OCC1CC1=CC=C2C(=C1)C(CC[N+](C)(C)[O-])=CN2[Si](C)(C)C(C)(C)C3199.9Semi standard non polar33892256
Zolmitriptan N-Oxide,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C(=O)OCC1CC1=CC=C2C(=C1)C(CC[N+](C)(C)[O-])=CN2[Si](C)(C)C(C)(C)C3204.2Standard non polar33892256
Zolmitriptan N-Oxide,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N1C(=O)OCC1CC1=CC=C2C(=C1)C(CC[N+](C)(C)[O-])=CN2[Si](C)(C)C(C)(C)C3312.1Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Zolmitriptan N-Oxide GC-MS (Non-derivatized) - 70eV, Positivesplash10-000i-6290000000-68a34b3d5a73d8d923212021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Zolmitriptan N-Oxide GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-27Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID8510598
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]